Trial intelligence / Profile preview

MBSR vs FibroQoL vs TAU in Fibromyalgia (EUDAIMON)

NCT02561416Phase 3Completed

Sponsor
Fundació Sant Joan de Déu
Start
Jan 2016
Primary completion
Jun 2018
Countries
1
01

Overview

Phase 3, randomised, open-label trial (3 arms), sponsored by Fundació Sant Joan de Déu. Primary endpoints: Revised Fibromyalgia Impact Questionnaire at 12 months, Client Service Receipt Inventory at 12 months and 4 more. Started Jan 2016; status: completed.

Beyond the preview

Go deeper on NCT02561416.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02561416.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call